Preserving the Sequence of an Antibody of Interest

Securing the Genetic Information of an Antibody

Monoclonal antibodies represent essential tools in biomedical research, diagnostics, and the development of therapeutic treatments. Their production generally relies on producer cell lines, such as hybridomas.

The loss or alteration of a cell line can result in the disappearance of an antibody of interest.
To avoid this risk, it is possible to preserve the genetic sequence of the antibody, in order to durably retain the information necessary for its reproduction.

The determination and archiving of these sequences thus constitute an important step in securing a scientific or industrial project.

What Is the Value of Preserving an Antibody Sequence?

Preserving the genetic sequence of an antibody makes it possible to:

  • preserve the genetic information associated with an antibody of interest,
  • secure a research or development project,
  • avoid the permanent loss of an antibody in the event of cell line disappearance,
  • facilitate the subsequent reproduction or characterization of the antibody.

This approach makes it possible to retain a durable genetic record of the antibody, independent of the viability of the producer cells.

How Is an Antibody Sequence Determined?

Preserving an antibody relies on identifying the genetic sequences encoding the heavy and light chains of the antibody.

These sequences can be obtained from producer cells, such as hybridomas, using appropriate genetic sequencing techniques.

The analysis makes it possible to precisely identify the variable regions responsible for the antibody's specificity, in order to retain the information necessary for its reproduction or study.

A Key Step in Securing an Antibody of Interest

Determining and archiving the genetic sequence of an antibody constitute a strategic approach to:

  • protect an antibody developed during a research project,
  • preserve unique genetic information,
  • facilitate future analyses or scientific developments.

This approach makes it possible to ensure the long-term scientific value of an antibody, independent of the constraints associated with cell line preservation.